US State Secretary, Egypt FM discuss bloodshed in Gaza, stress strategic partnership    Egypt's Al-Sisi in Paris for Sudan Transition Conference    Sundance Institute names 20 fellows across upcoming summer labs    Grand Egyptian Museum opening to be as impressive as Royal Mummies Parade: El-Anani    Egypt to soon complete COVID-19 vaccination of tourism workers in Red Sea, South Sinai    EGP 308.3bn allocated to Egypt economic authorities to support services, development projects    Chief of Egypt's Financial Regulator elected as committee head at IOSCO    Washington calls for resumption of GERD talks    Egypt, Saudi Arabia aim to restore calm in Palestinian territories    Comedy actress Nadia Al-Iraqia passes away from COVID-19    Egypt's Health Ministry launches awareness campaigns against COVID-19    Sudan pledges to investigate killing of 2 protestors during peaceful sit-in    Egypt scales up readiness of hospitals nationwide for Eid Al-Fitr holidays    Egyptian hospitals in Sinai on alert amid Israeli aggression on Gaza    Egypt announces Thursday 1st day of Eid Al-Fitr    Nuweiba: Egypt's paradise of serenity    Egypt's trade deficit down 1.2% to $3.34bn in February 2021: CAPMAS    Global economic recovery to improve debt service coverage ratios: Moody's    Egypt's current account deficit jumps to $7.6 bln in 1H of FY2020/21: CBE    India signs an agreement to buy 300,000 doses of Remdesivir from Eva Pharma    Egypt will locally manufacture first 2m Sinovac vaccine doses by June-end    Turkey seeks to restore 'historic unity' with Egyptian people: Erdogan    Elneny's Arsenal targets 'remontada' in Europa League semi-finals    Zamalek eye return to victories at expense of Smouha in Egyptian Premier League    Al Ahly face injuries as they take on Al Ittihad Alexandria    Egypt buys 30 Rafale fighter jets from France    Direct flights between Russia and Egypt will resume in June, Ambassador    Egypt's Ahly is establishing a new stadium, expected to be 'sports complex'    Blinken presses Ethiopia's Abiy to ensure full withdrawal of Eritrean troops from Tigray    Forces opposed to Somali president control parts of Mogadishu    Nine people executed in Egypt over Kerdasa police killings in 2013    UEFA investigating Ibrahimovic's alleged ties to betting company    61 doctors died from coronavirus since start of April: Egypt's medical syndicate    Egypt targets 5.6% inflation rate in FY2020/21, 6% in FY2021/22    Egypt allocates EGP 132 bln to modernise railway system: Transport minister    Real Madrid not thinking about any Super League sanctions: Zidane    Total declares force majeure on Mozambique LNG after attacks    All the winners at the 93rd Academy Awards    Egypt's Ahly granted approval to build new stadium on Cairo outskirts    Aswan Int'l Women's Film Festival dedicates 5th edition to Kawthar Heikal    BREAKING: Egypt's information minister Osama Heikal resigns amid parliamentary criticism    'War was not Egypt's aim, but peace was the ultimate goal,' Sisi says on Sinai Liberation Day anniversary    Factbox: Key nominations for the 2021 Academy Awards    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    Veteran Egyptian journalist Makram Mohamed Ahmed passes away at 86    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Coronavirus variants deadlier, more contagious; some may thwart vaccines
Published in Ahram Online on 21 - 03 - 2021

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus
Multiple variants can "escape" vaccines
Antibodies induced by the Moderna Inc and Pfizer Inc/BioNTech SE vaccines are dramatically less effective at neutralizing some of the most worrying coronavirus variants, a new study suggests. Researchers obtained blood samples from 99 individuals who had received one or two doses of either vaccine and tested their vaccine-induced antibodies against virus replicas engineered to mimic 10 globally circulating variants.
Five of the 10 variants were "highly resistant to neutralization," even when volunteers had received both doses of the vaccines, the researchers reported on Friday in Cell. All five highly resistant variants had mutations in the spike on the virus surface - known as K417N/T, E484K, and N501Y - that characterize a variant rampant in South Africa and two variants spreading rapidly in Brazil. In keeping with previous studies, the proportion of neutralizing antibodies dropped 5- to 6-fold against the variants discovered in Brazil.
Against the variant discovered in South Africa, neutralization fell 20- to 44-fold. A variant circulating now in New York has the E484K mutation. "While studies of the New York variant are ongoing, our findings suggest that similar variants harboring E484K may be harder for vaccine-induced antibodies to neutralize," said study leader Alejandro Balazs of Harvard University and the Massachusetts General Hospital. "Despite our results," he added, "it's important to consider that vaccines raise other kinds of immune responses which could protect against developing severe disease."
Variant identified in UK is deadlier
The coronavirus variant first identified in the UK, known as B.1.1.7, is deadlier than other variants circulating there, a new study appears to confirm.

Researchers analyzed data on 184,786 people in England diagnosed with COVID-19 between mid-November and mid-January, including 867 who died. For every three people who died within four weeks after being infected with another variant, roughly five died after becoming infected with B.1.1.7, according to a paper posted on medRxiv ahead of peer review. Overall, the risk of death with B.1.1.7 was 67% higher than the risk with other variants in England, the authors said.

As with earlier variants, patients' risk of death increased with age, male gender, and pre-existing medical conditions. B.1.1.7 is now prevalent across Europe and predicted to become prevalent in the United States. "Crucially," the researchers wrote, "emerging data suggest that the currently approved vaccines for SARS-CoV-2 are effective against the B.1.1.7."
Variant identified in Brazil is doubly infectious
Between November and January in Manaus, Brazil, the frequency of COVID-19 cases involving the P.1 coronavirus variant increased from non-existent to 73%, and the number of infections there quadrupled compared to what the city experienced in the first wave of the pandemic, according to a report posted on medRxiv ahead of peer review.
The greater infectiousness of the P.1 variant likely contributed to that, the report suggests. Based on national health surveillance data, the authors estimate that the P.1 variant is roughly 2.5 times more transmissible than previous variants circulating in Manaus.
The spread of P.1 occurred despite the fact that 68% of the city's population had already been infected by the original strain of the coronavirus, the researchers noted. In their analysis, the risk of reinfection with P.1 was low. The ability of the variant to cause severe disease, or its pathogenicity, is still unclear. "The P.1 variant has already been detected in at least 25 countries," the authors said. "This calls for urgent ... studies of the P.1 variant, since greater transmissibility and pathogenicity can drive even well-prepared health systems to collapse."


Clic here to read the story from its source.